Analyst Ratings for Watson Pharmaceuticals (WPI)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/11/2013 | Goldman Sachs | N/A | Downgrade | Neutral (Buy) |
96.00 (100.00) |
87.99 (85.73) |
-2.57% | Details |
| 11/2/2012 | Piper Sandler | N/A | Upgrade | Overweight (Neutral) |
103.00 (77.00) |
87.71 (85.73) |
-2.26% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


